SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as the stock price hits new all-time highs, fueled by updates from the GTC event and potential new partnerships. The community is buzzing about the company's projected revenue growth and potential market cap, while also discussing whether the stock is overvalued. Trump's upcoming meeting with Jensen Huang and potential discussions about Nvidia's Blackwell chip with China are adding to the excitement.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending due to a rejected acquisition offer for Larvotto Resources, leading to community discussion about the company's next steps and valuation; Some traders speculate on a hostile takeover. Despite this setback, UAMY's existing government contracts and position as a domestic antimony producer remain key talking points, with some viewing the dip as a buying opportunity.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is trending amid discussions about Gravity SUV deliveries, new partnerships, and concerns over potential dilution. Community members are weighing the company's growth prospects against its cash burn rate and production targets. Recent collaborations and expansion plans are also being actively discussed.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending following news of Nvidia's $1 billion investment, sparking optimism around its role in AI-driven telecom and 6G technology. Community discussions revolve around potential breakouts and long-term growth, with some recalling Nokia's past prominence in the mobile phone market. The investment is seen as a validation of Nokia's pivot towards networking infrastructure and AI-related services, potentially positioning it as a key player in the future of telecommunications.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors gear up for the company's earnings report, anticipating discussion of AI and cloud growth. Community members are closely watching technical indicators and discussing potential price movements.  Speculation around the impact of the OpenAI partnership and the potential for a stock split are also fueling interest.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending following a substantial after-hours surge driven by record Q3 revenue and a significant partnership with Brookfield to supply AI data centers with clean energy. Community discussions revolve around the potential for continued growth, the company's valuation, and the possibility of a short squeeze given the high short interest. Bloom Energy's role in providing alternative energy solutions for data centers is also a key talking point, especially with the increasing demand from AI operations.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending amid discussions surrounding a recent partnership with Nvidia, which the community believes could significantly impact the company's future revenue. Community members are actively debating the stock's valuation and potential for further growth, with some highlighting upcoming earnings as a key catalyst. Bullish sentiment is strong, with some traders predicting a continued climb.

Another token of MartyrFi narrative to remember Tyke the Elephant. She was a female African bush elephant captured as a baby and shipped to the United States, where She was brutalised and instilled fear upon during the training for the circus, and shot 87 times whilst on the streets of Honolulu, Hawaii. She died of her injuries. She was forgotten but she will have a special place in our hearts forever  The token is built to remember and honour Tyke the elephant. The project is also built around being charitable towards elephants who may go through the same sort of abuse.

Tyke The Elephant

Tyke The Elephant ($TYKE) is gaining traction, particularly within the Phantom Wallet community, with many highlighting its potential. The community is discussing its 'moonshot vibes' and breakout potential, drawing comparison to established cryptocurrencies like Bitcoin and Solana. Bullish sentiment appears to be fueled by the token's perceived momentum.

The RealReal, Inc. is an online marketplace for consigned luxury goods, which engages in the consignment of luxury goods across multiple categories, including women's, men's, kids, jewelry, watches, home, and art. It sells pieces from designers such as Chanel, Christian Louboutin, Gucci, Hermes, Louis Vuitton, Prada, Celine, Jimmy Choo, Burberry, and Valentino. The company was founded by Julie Wainwright and Marcy Carmack on March 29, 2011 and is headquartered in San Francisco, CA.

Therealreal Inc

The RealReal (REAL) is trending amid mixed sentiment, with some users expressing concerns about the company's practices and financials, even alleging fraud related to consignment. Bullish investors point to potential benefits from tariffs, strong Q2 earnings results, and AI-driven efficiency gains while short-sellers express concerns about cash flow and debt, forecasting a price decline.

Based Chad

Based Chad is trending as community members highlight its strong accumulation and potential for a rally, especially with Coinbase executives showing interest. Discussions also center around the meme's cultural relevance and its presence on the Base network. Some users are noting the upcoming AAA video game.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Believe Zymeworks (ZYME) Could Rally 25.73%: Here's is How to Trade

The mean of analysts' price targets for Zymeworks (ZYME) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Next-Generation Targeted Therapies Reshape Precision Oncology Landscape

Next-Generation Targeted Therapies Reshape Precision Oncology Landscape Next-Generation Targeted Therapies Reshape Precision Oncology Landscape PR Newswire VANCOUVER, BC, Oct. 15, 2025 USA News Group...

Zymeworks Inc. (ZYME) is a Great Momentum Stock: Should You Buy?

Does Zymeworks Inc. (ZYME) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zymeworks Inc. (ZYME) on Tuesday announced its decision to discontinue clinical development of ZW171, designed to target certain cancers.ZW171 is designed to address cancers driven by Mesothelin, a cell-surface protein overexpressed in certain cancers, including gynecological, thoracic, and digestive system cancers. The company was testing the drug in an early-stage trial in patients with ovarian cancer and non-small cell lung cancer.At the time of writing, <a href="https://stocktwits.com/symbol/ZYME">ZYME stock</a> was down by over 17% in Tuesday’s pre-market session. On Stocktwits, retail sentiment around ZYME stock, however, rose from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.<figure class="image"><img style="aspect-ratio:655/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_02_at_8_57_28_AM_png_feb9611316.webp" alt="ZYME's Sentiment Meter and Message Volume as of 8:57 a.m. ET on Sept. 2, 2025 | Source: Stocktwits" width="655" height="61"><figcaption>ZYME's Sentiment Meter and Message Volume as of 8:57 a.m. ET on Sept. 2, 2025 | Source: Stocktwits</figcaption></figure>After establishing a maximum tolerated dose in the early-stage trial, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.zymeworks.com/news-releases/news-release-details/zymeworks-announces-decision-discontinue-clinical-development">determined</a> that further dose escalation would be unlikely to support a benefit-risk profile consistent with the company’s intent to develop it as a standalone therapy.While ongoing participants in the trial will continue treatment at the discretion of their investigator, participants who have discontinued treatment will continue safety follow-up as per the study protocol, Zymeworks said.Zymeworks CEO Kenneth Galbraith said that the outcome is “disappointing” given the promising preclinical activity observed with ZW171.“We continue to advance our broader product pipeline, including the ongoing Phase 1 trial of ZW191 and the initiation of a Phase 1 study for ZW251 expected in 2025. We are also preparing an IND filing for ZW209, our DLL3-directed trispecific T cell engager, planned in the first half of 2026,” he added.&nbsp;ZYME stock is up by 1% this year and nearly 29% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/merck-investigational-drug-shows-reduction-in-cholestrol-in-late-stage-trial/chv6ol3Rdnp">Merck’s Investigational Drug Shows Reduction In Cholesterol In Late-stage Trial</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Zymeworks Stock Tanks Over 17% After Cancer Drug Candidate Update

The company was testing the drug in an early-stage trial in patients with ovarian cancer and non-small cell lung cancer.

Equity

The company was testing the drug in an early-stage trial in patients with ovarian cancer and non-small cell lung cancer.


Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus

KOD's Q2 loss widens as it ramps up clinical studies for three key eye disease treatments with pivotal data readouts planned.

Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus

IMVT reports a narrower Q1 loss, as spotlight remains on IMVT-1402's broad clinical potential across multiple indications.

Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zymeworks (ZYME) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates

Zymeworks (ZYME) delivered earnings and revenue surprises of +105.77% and +256.65%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains?

Zymeworks (ZYME) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

All You Need to Know About Zymeworks (ZYME) Rating Upgrade to Buy

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Zymeworks BC Inc

Will Meta ($META) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Meta Platforms Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.29	--	--	N/A
Q2 '25	-$0.48	$0.03	106.22%	BEAT
Q1 '25	-$0.68	-$0.30	56.12%	BEAT
Q4 '24	-$0.10	-$0.31	-211.88%	MISSED
Q3 '24	-$0.40	-$0.39	1.71%	BEAT

ZYME
Zymeworks Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest ZYME News

ZYMEZymeworks Inc